CorriXR Therapeutics Revenue

Biotechnology Research • Newark, Delaware, United States • 1-10 Employees

CorriXR Therapeutics revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	$6,000,000

Key Contact at CorriXR Therapeutics

Eric B. Kmiec

Chief Executive Officer

Company overview

Headquarters	550 S College Ave, Suite 107, Newark, Delaware 19713, US
Phone number	+13026235305
Website	corrixr.com
NAICS	541714
Founded	2022
Employees	1-10
Socials

CorriXR Therapeutics Email Formats

CorriXR Therapeutics uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@corrixr.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@corrixr.com	100%

About CorriXR Therapeutics

CorriXR Therapeutics is on the clinical frontier of gene editing as a transformative pre-clinical stage biotechnology company with a ground-breaking in vivo gene editing therapeutic platform technology. CorriXR Therapeutics advances CRISPR/Cas gene editing technology to develop new genetic medicines directed against drug-resistant solid tumors.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

CorriXR Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore CorriXR Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2022-08-15	3	$5,000,000
2024-02-16	1	N/A
2024-02-16	3	N/A
2024-07-27	9	N/A
2025-09-19	4	$1,000,000

Funding Insights

$6,000,000

Total funding amount

$1,000,000

Most recent funding amount

Number of funding rounds

CorriXR Therapeutics Tech Stack

Discover the technologies and tools that power CorriXR Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Adobe Fonts

Font scripts

Modernizr

JavaScript libraries

Lodash

JavaScript libraries

reCAPTCHA

Security

Squarespace Commerce

Ecommerce

Google Tag Manager

Tag managers

GoDaddy

Hosting

Stimulus

JavaScript frameworks

HSTS

Security

Open Graph

Miscellaneous

core-js

JavaScript libraries

Google Analytics

Analytics

Frequently asked questions

CorriXR Therapeutics is located in Newark, Delaware, US.

You can reach CorriXR Therapeutics at +13026235305.

CorriXR Therapeutics generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.

CorriXR Therapeutics has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

CorriXR Therapeutics was founded in 2022, making it 4 years old. The company has established itself as a significant player in its industry over this time.

CorriXR Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

CorriXR Therapeutics has raised a total of $6,000,000 across 5 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at CorriXR Therapeutics

Eric B. Kmiec

Chief Executive Officer

4.8

40,000 users